#LobularBreastCancerAwarenessDay: New research from CU Cancer Center member Matthew Sikora, PhD, seeks ways to potentially open up a new treatment option for people with this challenging cancer type ⬇️ https://news.cuanschutz.edu/cancer-center/sikora-lobular-breast-cancer

Amazing research being done to understand and cure ILC breast cancer!! news.cuanschutz.edu/cancer-cente... @mjsikora.bsky.social

🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social 📅 Aug 11 |🕛 12–1PM MST |💻 Virtual Topic: PARP Inhibitors Register today! bit.ly/40k8dUE

Dr. Kian Behbakht and AOA Dx CEO Oriana Papin-Zoghbi spoke with 360Dx about the urgent need for better ovarian cancer diagnostics, highlighting how vague symptoms delay care and the role of innovation and data in closing this critical diagnostic gap. #OvarianCancer 👏Full article: bit.ly/3ZMxqa3

For Uterine Cancer Awareness Month, learn about the two primary types of uterine cancer and the symptoms to watch out for: bit.ly/45vieSg

Undermining Women’s Health Research — Gambling with the Public’s Health | New England Journal of Medicine www.nejm.org/doi/full/10.... Fight for Women’s Health! @cucancerbio.bsky.social

Insights on IHC testing for clinical decision making - put together by our talented Gyn Onc Path team! Shout to Dr. Rebecca Wolsky. @cucancercenter.bsky.social www.sciencedirect.com/science/arti...

New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates ocrahope.org/news/new-glo...

🔬Curious about gynecologic cancer research but not a science expert? Join CU DRS & CGCA’s new virtual, quarterly series making cutting-edge research easy to understand @uccc-gorg.bsky.social 📅 May 12 |🕛 12–1PM MST |💻 Virtual Topic: Ovarian cancer early detection Register today! loom.ly/7owjJ-g

MSTP retreat - Scott presenting his research findings on targeting the epigenetic environment of therapy resistant ovarian cancer. @cucancercenter.bsky.social @cugynonc.bsky.social

MSTP retreat - Raquel presenting her exciting research on Alt-EJ and PARP inhibitors. @cucancercenter.bsky.social @cugynonc.bsky.social

Early detection for ovarian cancer. Drs. Helm and Behbakht published a study on symptom screening feasibility. www.sciencedirect.com/science/arti... @cucancercenter.bsky.social @cugynonc.bsky.social @powelldrescher.bsky.social @targetovarian.bsky.social

Last month, Taylor Benson, PhD, showcased her work on identifying early biomarkers for ovarian clear cell carcinoma (OCCC) at STEM Poster Day, hosted by @projbridgeco.bsky.social! #CancerResearch #CUAnschutz Check out her poster: www.cuanschutz.edu/docs/librari...

A sad few days for the NIH, a tragedy for sure. Sad days for science, education, innovation in the US and, truly, globally. Wow

Early detection of ovarian cancer! www.cbsnews.com/colorado/new... @cugynonc.bsky.social @ocacademy.bsky.social

Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz

At the Keystone Tumor Metabolism meeting! Just listened to an incredible presentation by @airdlab.bsky.social highlighting the intersection of p16/metabolism/immunology! Check out the BiorXiv pre-print www.biorxiv.org/content/10.1...

Annika rightfully points out that though this is positive, this is going to SERIOUSLY burden an NIH staff that is actively being further depleted. Be nice to your SROs, POs, and GMSs, folks...

There is SO MUCH RESEARCH that will simply NOT HAPPEN without these funds. We will be set back DECADES. And for what? Greed. Hate. Spite. I am crushed for the team at CDMRP that continues to support us, and for the work that will never be done.

Today the @cugynonc.bsky.social hosted Dr. Lea to honor Carol Goldstein! Carol was passionate about ovarian cancer early detection and symptom screening! Dr. Lea discussing hereditary ovarian risk. @tinaswish.bsky.social

8 years ago @asbmb.bsky.social gave me +18 more trainees a crash course in advocacy for their DC Hill Day. With NIH slashing indirect costs effective immediately, university Govt Affairs teams will be swamped. Here's 10 tips for scientists contacting lawmakers +pics from Denver's 2017 Science March.

Eager to hear my Rep, @degette.house.gov , and @bennet.senate.gov, respond to these seismic cuts. This isn't cost cutting or trimming fat, it's destroying the foundation of research and medical infrastructure in this country. Heartened to see @murray.senate.gov's response.

This is what amounts to an ILLEGAL & indiscriminate funding cut for research centers everywhere. It will mean shuttering labs across the country, layoffs in red & blue states, and derailing lifesaving research on everything from cancer to opioid addiction. We all need to speak out to save lives.